(NYSE: BIO) Bio Rad Laboratories's forecast annual revenue growth rate of 4.22% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.6%.
Bio Rad Laboratories's revenue in 2024 is $2,671,262,000.On average, 2 Wall Street analysts forecast BIO's revenue for 2024 to be $76,379,501,217, with the lowest BIO revenue forecast at $76,375,223,452, and the highest BIO revenue forecast at $76,383,778,982. On average, 2 Wall Street analysts forecast BIO's revenue for 2025 to be $83,235,903,600, with the lowest BIO revenue forecast at $80,958,136,117, and the highest BIO revenue forecast at $85,513,671,083.
In 2026, BIO is forecast to generate $88,362,092,471 in revenue, with the lowest revenue forecast at $88,362,092,471 and the highest revenue forecast at $88,362,092,471.